Find and Pitch Jounalists, Get Your Story Covered

Tags: selenium gastric bypass endocrinology remission weight loss

	Profile	Recent Articles on Subject
1	Kennedy Ferruggia, Assistant Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey pharmacyhealthcarejournalism	Dual Immunotherapy Shows Promise in MSI-H/dMMR Metastatic Colorectal Cancer - 26 days ago RHB-104 Plus Standard of Care Offers Extended Treatment for Crohn Disease - 7 months ago Dramatic Tumor Regression Was Displayed in New Approach to CAR T Therapy - 11 months ago FDA Approves Ravulizumab-cwvz for Neuromyelitis Optica Spectrum Disorder - 11 months ago FDA Grants Breakthrough Device Designation for Neuroimmune Modulation Platform To Treat MS - 12 months ago Researchers Announce Positive Trial Data for the Use of Remibrutinib In Chronic Spontaneous Urticaria - over 1 year ago Treatment With Anifrolumab-fnia Shows Promising Rates of Remission for Lupus - over 1 year ago Esketamine in Combination with Oral Antidepressant Could Aid Treatment-Resistant Depression - over 1 year ago Study Finds Obesity Remission Rates Are Lower Than Overweight Remission Rates in Children - over 1 year ago
2	Mike Bassett MedPage Today Explains healthcare complexities. Not endorsements. New York, New York Healthcare journalism	Mutation Clearance After Transplant Linked to Better Outcomes in Myelofibrosis - about 2 months ago New CAR-T Drug Induces Durable Remissions in ALL, Published Data Show - 3 months ago Real World CAR T-Cell Therapy Outcomes 'Favorable' in Relapsed/Refractory Myeloma - 5 months ago Infections the Main Cause of Nonrelapse Mortality After CAR-T for Blood Cancers - 6 months ago A Blenrep Comeback? Cancer Vaccine for Dogs; U.K. Snubs Enhertu - 12 months ago Novel Therapy Promising for Radiation-Induced Oral Mucositis - 12 months ago Vaccine 'Promising' for Delaying Relapse in KRAS-Mutated Pancreatic Cancer, CRC - about 1 year ago Axatilimab Shows Efficacy in Recurrent/Refractory GVHD - about 1 year ago Novel Therapy Reduced Transfusion Dependence in Lower-Risk MDS - about 1 year ago RET Inhibitor Posts Frontline Wins in Medullary Thyroid Cancer, NSCLC - over 1 year ago
3	Greg Laub MedPage Today Director of Video at MedPage Today. Screenwriter, previous managing editor. videographyscreenwritingediting	Integrating MRD in Myeloma: Guidance for Therapy Escalation and De-escalation - 2 months ago Pushing Toward Asthma Remission With New Endpoints, Imaging Advances - 4 months ago "I'm Doing Great, So When Can I Stop My Atopic Dermatitis Treatment?" - about 1 year ago A Novel Mechanism of Action in Treating Relapsing MS - over 1 year ago New Guselkumab Responses in Ulcerative Colitis Emerge After 12 Weeks - over 1 year ago New Data on CD40 Ligand Inhibitor for Relapsing MS - over 1 year ago MS Treatment-Discontinuation Study Terminated After Disease Activity Returns - over 1 year ago
4	Angus Chen STAT News Undignified, unfunny journalist. Health, cancer coverage at STAT News. journalismhealthcancer researchSTAT News	STAT+: For a leukemia that keeps returning, AbbVie drug may offer chance for a deep remission - 3 months ago STAT+: A targeted therapy shows it can offer a ‘last, great chance’ for some acute leukemia patients - about 1 year ago
5	Ian Ingram MedPage Today Deputy Managing Editor. MedPage Today. New York, New York medical journalismediting	Dual Targeted CAR-T Yields 99% Response Rate in Pediatric ALL - 3 months ago Menin Inhibitor Yields 63% ORR in Heavily Pretreated Acute Leukemia - about 1 year ago MRD Tied to Allo-Transplant Benefit in NPM1-Mutated Acute Myeloid Leukemia - about 1 year ago
6	John Gever MedPage Today MedPage Today factotum. Pittsburgh, Pa. Healthcare journalism	Off-the-Shelf Drug Matches CAR-T Effects in Refractory Lupus - 6 months ago Another Study Backs Treatment for Preclinical Rheumatoid Arthritis - about 1 year ago
7	Kristen Monaco MedPage Today	Antidepressant Discontinuation; Gun Suicide Prevention; REM Disorder Breakthrough - 9 months ago T2D Remission Common With Gastric Bypass; Selenium for Hashimoto's; Cereal Chemicals - about 1 year ago
8	Alana Hippensteele, Managing Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey pharmacyhealthcarejournalism	Relapsed/Refractory Multiple Myeloma Treatment Advances With Three BiTE Therapy Options - 11 months ago Ibrutinib Plus Venetoclax With MRD-Directed Duration of Treatment Is a New Standard of Care Regimen for Previously Untreated CLL - about 1 year ago
9	Ashley Gallagher, Associate Editor Pharmacy Times One of Cabra girls on GoggleboxIRL. Dublin City, Ireland televisionentertainment	Study: Only 40% of Adults With Childhood Asthma Experience Remission - 12 months ago Belantamab Mafodotin Met Primary Endpoint for Those with Relapsed, Refractory Multiple Myeloma - over 1 year ago Subcutaneous Lecanemab Demonstrates Greater Amyloid Plaque Removal Than Intravenous Lecanemab - over 1 year ago
10	Adam Feuerstein STAT News Reporter at STATnews. Dog lover. Polk Award winner. Boston, Massachusetts biotech reporting	STAT+: Madrigal wins first U.S. approval for drug to treat liver disease MASH - 12 months ago STAT+: First medicine developed to treat MASH expected to be approved soon - 12 months ago

Journalists covering remission